Safety evaluation of orally administered superoxidation electrolyzed solution with neutral pH in clinically healthy subjects or without decompensated diseases - ORALSES
EVALUATION OF HOMEOSTEC INTRAVENOUS APPLICATION IN PATIENTS WITH CHRONIC MANIFESTATIONS OF CHIKUNGUNYA VIRUS INFECTION: CLINICAL TRIAL PHASE II-III - CHIKCRONTX2
Toxicity of the intravenous application of Homeostec in patients with chronic manifestations of Chikungunya virus infection: Clinical Trial Phase I. - CHIKCRONTX
100 Clinical Results associated with Esteripharma SA
0 Patents (Medical) associated with Esteripharma SA
100 Deals associated with Esteripharma SA
100 Translational Medicine associated with Esteripharma SA